Clinical implications of fetuin-A.

Peter Jirak; Lars Stechemesser; Elena Moré; Michael Franzen; Albert Topf; Moritz Mirna; Vera Paar; Rudin Pistulli; Daniel Kretzschmar; Bernhard Wernly; Uta Hoppe; Michael Lichtenauer; Hermann Salmhofer

doi:10.1016/bs.acc.2018.12.003

Clinical implications of fetuin-A.

Peter Jirak (Erstautor/-in), Lars Stechemesser (Co-Autor/-in), Elena Moré, Michael Franzen (Co-Autor/-in), Albert Topf (Co-Autor/-in), Moritz Mirna (Co-Autor/-in), Vera Paar (Co-Autor/-in), Rudin Pistulli, Daniel Kretzschmar, Bernhard Wernly (Co-Autor/-in), Uta Hoppe (Co-Autor/-in), Michael Lichtenauer^* (Co-Autor/-in), Hermann Salmhofer (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsklinik für Innere Medizin 2 - Kardiologie, Internistische Intensivmedizin und Notaufnahme
Universitätsklinik für Innere Medizin 1 - Gastroenterologie- Hepatologie, Nephrologie, Stoffwechsel und Diabetologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

37 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	79-130
Fachzeitschrift	ADVANCES IN CLINICAL CHEMISTRY
Jahrgang	89
DOIs	https://doi.org/10.1016/bs.acc.2018.12.003
Publikationsstatus	Veröffentlicht - 2019

Zugriff auf Dokument

10.1016/bs.acc.2018.12.003

Dieses zitieren

@article{178122be351c4f1d8ee617f2e8690214,

title = "Clinical implications of fetuin-A.",

keywords = "CHRONIC KIDNEY-DISEASE, SMOOTH-MUSCLE-CELLS, CONTAINING CALCIPROTEIN PARTICLES, PERIPHERAL ARTERIAL-DISEASE, INTIMA-MEDIA THICKNESS, STAGE RENAL-DISEASE, ALPHA(2)-HEREMANS-SCHMID GLYCOPROTEIN/FETUIN-A, RECOMBINANT ALPHA2-HS GLYCOPROTEIN, MECHANISMS LINKING OBESITY, INCIDENT DIABETES-MELLITUS",

author = "Peter Jirak and Lars Stechemesser and Elena Mor{\'e} and Michael Franzen and Albert Topf and Moritz Mirna and Vera Paar and Rudin Pistulli and Daniel Kretzschmar and Bernhard Wernly and Uta Hoppe and Michael Lichtenauer and Hermann Salmhofer",

note = "Jirak; Topf; Mirna; Paar; Wernly; Hoppe; Lichtenauer: Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University, Salzburg, Austria; Stechmesser; More; Salmhofer: Department of Internal Medicine I, Divisions of Nephrology and Endocrinology, Paracelsus Medical University, Salzburg, Austria",

year = "2019",

doi = "10.1016/bs.acc.2018.12.003",

language = "English",

volume = "89",

pages = "79--130",

journal = "ADVANCES IN CLINICAL CHEMISTRY",

issn = "0065-2423",

publisher = "AAOS",

}

TY - JOUR

T1 - Clinical implications of fetuin-A.

AU - Jirak, Peter

AU - Stechemesser, Lars

AU - Moré, Elena

AU - Franzen, Michael

AU - Topf, Albert

AU - Mirna, Moritz

AU - Paar, Vera

AU - Pistulli, Rudin

AU - Kretzschmar, Daniel

AU - Wernly, Bernhard

AU - Hoppe, Uta

AU - Lichtenauer, Michael

AU - Salmhofer, Hermann

N1 - Jirak; Topf; Mirna; Paar; Wernly; Hoppe; Lichtenauer: Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University, Salzburg, Austria; Stechmesser; More; Salmhofer: Department of Internal Medicine I, Divisions of Nephrology and Endocrinology, Paracelsus Medical University, Salzburg, Austria

PY - 2019

Y1 - 2019

KW - CHRONIC KIDNEY-DISEASE

KW - SMOOTH-MUSCLE-CELLS

KW - CONTAINING CALCIPROTEIN PARTICLES

KW - PERIPHERAL ARTERIAL-DISEASE

KW - INTIMA-MEDIA THICKNESS

KW - STAGE RENAL-DISEASE

KW - ALPHA(2)-HEREMANS-SCHMID GLYCOPROTEIN/FETUIN-A

KW - RECOMBINANT ALPHA2-HS GLYCOPROTEIN

KW - MECHANISMS LINKING OBESITY

KW - INCIDENT DIABETES-MELLITUS

U2 - 10.1016/bs.acc.2018.12.003

DO - 10.1016/bs.acc.2018.12.003

M3 - Original Article

C2 - 30797472

SN - 0065-2423

VL - 89

SP - 79

EP - 130

JO - ADVANCES IN CLINICAL CHEMISTRY

JF - ADVANCES IN CLINICAL CHEMISTRY

ER -